Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a new revision entry 'Revision: v3.3.4' in the update history, replacing the prior 'Revision: v3.3.3'. This update pertains to version history and does not modify study details or criteria.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedIntroduced a dedicated Locations section highlighting Colorado sites; the Colorado Locations header was removed and location information was reorganized.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding status notice from the page. The rest of the trial details remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedNo meaningful additions or deletions were detected that affect the study details page; the content remains consistent with the prior version.SummaryDifference0.5%

- Check103 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.